-Massive Bio, a global leader in artificial intelligence-driven solutions for oncology, clinical trial matching, and patient navigation, and the Latin Am...
SCIEX, a Danaher company and leader in life science analytical technologies, announced new solutions designed to help clinical laboratories move from sam...
“We delivered outstanding performance in the second quarter, reflecting the strength of our proven growth strategy, our team’s excellen...
Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, announced that the UK Medicines and Healthcare ...
FDA supports advancement of IVMED-85 into Phase 2 clinical development for pediatric myopia and provides alignment on key elements of the develop...
ArisGlobal brings a mission-critical, AI-native platform spanning regulatory, safety, quality and medical affairs that serves as a single sourc...
The recent Bundibugyo Ebola virus outbreak underscored the limitations of relying solely on highly targeted diagnostics, highlighting the need for more ada...
Enterprise-grade Signals software with guided onboarding positioned specifically for early-stage biotechs Science-first setup with ready-to-use...
Agreement provides Incyte the rights to develop and commercialize ENHANZE® with its mutCALR development program and an option to nominate up to...
BW-41012 represents the eighth clinical candidate from Argo's innovative RNAi pipeline, and is being evaluated for the prevention of thromboembolic disea...
AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of ...
ARUP Laboratories announced the launch of ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry. The new assay will characte...
Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding ...
Approval of iohexol injection 350 mg iodine/mL in 50 mL, 75 mL and 100 mL vials, and 300 mg iodine/mL in 50 mL vial, significantly expands Amneal&rsquo...
© 2026 Biopharma Boardroom. All Rights Reserved.
